secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tvardi Therapeutics, Inc. (TVRD)
CIK:        0001346830
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001104659-26-024676
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tvardi Therapeutics announces June 9, 2026 annual meeting; sets proposal deadlines
--------------------------------------------------------------------------------

- Annual meeting of stockholders scheduled for June 9, 2026.
- Rule 14a-8 stockholder proposals for proxy inclusion must be received by March 16, 2026.
- Advance notice for director nominations and other business under bylaws due March 16, 2026.
- Universal proxy rule (Rule 14a-19) notices for director nominees due April 10, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1346830/000110465926024676/0001104659-26-024676-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1346830/000110465926024676/tm268178d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-024676

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer